106 related articles for article (PubMed ID: 1864763)
1. Aerobic dehalogenation of halothane showing different substrate dependency from anaerobic dehalogenation in liver microsomes of guinea pig.
Nakao M; Fujii K; Kinoshita H; Yuge O; Morio M
Hiroshima J Med Sci; 1991 Mar; 40(1):23-8. PubMed ID: 1864763
[TBL] [Abstract][Full Text] [Related]
2. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes.
Fujii K
Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490
[TBL] [Abstract][Full Text] [Related]
3. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
4. Isoflurane increases the anaerobic metabolites of halothane.
Rahman M; Fujii K; Sato N; Yuge O
J Appl Toxicol; 1994; 14(1):43-6. PubMed ID: 8157869
[TBL] [Abstract][Full Text] [Related]
5. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.
Karashima D; Hirokata Y; Shigematsu A; Furukawa T
J Pharmacol Exp Ther; 1977 Nov; 203(2):409-16. PubMed ID: 909072
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of corticoids on reductive halothane dehalogenation.
Fujii K
Drug Metabol Drug Interact; 1995; 12(1):37-43. PubMed ID: 7555000
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
Ahr HJ; King LJ; Nastainczyk W; Ullrich V
Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
[TBL] [Abstract][Full Text] [Related]
8. A comparative study on reductive dehalogenation of halothane in liver, kidney and lung of the rabbit.
Inoue T; Fujii K; Kikuchi H; Yuge O; Morio M
Hiroshima J Med Sci; 1990 Dec; 39(4):115-8. PubMed ID: 2086561
[TBL] [Abstract][Full Text] [Related]
9. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6).
Minoda Y; Kharasch ED
Anesthesiology; 2001 Aug; 95(2):509-14. PubMed ID: 11506127
[TBL] [Abstract][Full Text] [Related]
10. The association of halothane-induced lipid peroxidation with the anaerobic metabolism of halothane: an in vitro study in guinea pig liver microsomes.
Sato N; Fujii K; Yuge O; Morio M
Hiroshima J Med Sci; 1990 Mar; 39(1):1-6. PubMed ID: 2373636
[TBL] [Abstract][Full Text] [Related]
11. Reductive halothane metabolite formation and halothane binding in rat hepatic microsomes.
Baker MT; Van Dyke RA
Chem Biol Interact; 1984 Apr; 49(1-2):121-32. PubMed ID: 6722932
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
Baker MT; Bates JN
Drug Metab Dispos; 1988; 16(2):169-72. PubMed ID: 2898328
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the reductive metabolism of halothane by microsomal cytochrome b5 in rat liver.
Tamura S; Kawata S; Sugiyama T; Tarui S
Biochim Biophys Acta; 1987 Dec; 926(3):231-8. PubMed ID: 3689822
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of gomisi on reductive metabolism of halothane.
Jiaxiang N; Fujii K; Sato N; Yuge O
J Appl Toxicol; 1993; 13(6):385-8. PubMed ID: 8288841
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
[TBL] [Abstract][Full Text] [Related]
16. Influence of disulfiram, diethyldithiocarbamate and carbon disulfide on the metabolic formation of trifluoroacetic acid from halothane in the rat.
Eckes L; Büch HP
Arzneimittelforschung; 1985; 35(9):1447-51. PubMed ID: 3002400
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of paraquat on biotransformation of halothane in rabbit liver microsomes.
Kawamoto M; Fujii K; Yuge O; Morio M
Hiroshima J Med Sci; 1989 Dec; 38(4):161-7. PubMed ID: 2637243
[TBL] [Abstract][Full Text] [Related]
18. S-ethylthiotrifluoroacetate enhancement of the immune response to halothane in the guinea pig.
Hastings KL; Schuman S; Brown AP; Thomas C; Gandolfi AJ
Adv Exp Med Biol; 1991; 283():739-44. PubMed ID: 2069050
[No Abstract] [Full Text] [Related]
19. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
Madan A; Parkinson A
Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of halothane in guinea pig liver slices.
Ghantous HN; Fernando J; Gandolfi AJ; Brendel K
Drug Metab Dispos; 1990; 18(4):514-8. PubMed ID: 1976077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
